PLTRMarch 2, 2026 at 7:42 AM UTCSoftware & Services

Palantir's Q4 Surge Highlights Growth Amid Persistent Valuation and Cash Flow Risks

Read source article

What happened

Palantir reported robust Q4 2025 results, with revenue up 70% year-over-year and adjusted EPS increasing 79%, driven by a 137% surge in commercial revenue from AIP adoption and expansion deals. Government momentum was bolstered by significant contracts like the $448 million ShipOS deal, deepening its entrenchment in defense programs. However, the DeepValue master report cautions that accounts receivable spiked to $1.042 billion in FY2025, consuming $450 million in operating cash flow and raising questions about growth quality. With valuation at 201x P/E and 218x EV/EBITDA, the stock prices in sustained conversion of the $11.2 billion Total Remaining Deal Value into collectible revenue without further working capital strain. Investors must monitor upcoming quarters for TRDV growth and AR normalization to confirm that the impressive top-line performance translates into durable cash generation.

Implication

The Q4 beat underscores Palantir's accelerating traction in AI and government markets, yet the sky-high multiples leave no room for error in execution. Persistent accounts receivable growth signals potential customer financing or extended terms, threatening cash flow sustainability if not reversed. The DeepValue report maintains a 'WAIT' rating, with conviction hinging on Q2 2026 updates showing TRDV exceeding $12.5 billion and AR declining sequentially. Investors should prioritize evidence of funded task orders from procurement vehicles like the DHS BPA and improved collections to validate backlog quality. Without these confirmations, the stock remains exposed to sharp de-rating despite headline growth numbers, making position sizing cautious until proof points emerge.

Thesis delta

The new article confirms Palantir's robust growth narrative but does not shift the investment thesis, which remains centered on valuation risk and working capital concerns. No change to the 'WAIT' rating is warranted until Q2 2026 results provide clarity on TRDV conversion and cash flow dynamics.

Confidence

Medium